Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Final Analysis Data and Exploratory Biomarker Analysis of a Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib Monotherapy for Untreated Patients with Nonsquamous NSCLC Harboring EGFR Mutations: the WJOG9717L Study.

Hirotsugu Kenmotsu,Kazuko Sakai,Keita Mori,Terufumi Kato,Shunichi Sugawara,Keisuke Kirita,Yasuto Yoneshima,Koichi Azuma,Kazumi Nishino,Shunsuke Teraoka,Ryo Koyama,Ken Masuda,Hidetoshi Hayashi,Ryo Toyozawa,Satoru Miura,Yuki Sato,Kazuhiko Nakagawa,Nobuyuki Yamamoto,Kazuto Nishio,Toshiaki Takahashi

JTO CLINICAL AND RESEARCH REPORTS（2024）

Cited 0|Views9
Key words
Non-small cell lung cancer,EGFR mutation,Osimertinib,Bevacizumab,TP53 mutation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined